Therapeutic interventions, diagnosed diseases, and drug treatments before onset of acute renal failure
| Cases (n = 71) | Controls (n = 101) | p Value | |
|---|---|---|---|
| Values are mean (SD) or number (%). | |||
| Endotracheal intubation | 60 (85%) | 70 (69%) | 0.035 |
| At birth | 46 (65%) | 47 (46%) | 0.027 |
| Subsequently | 14 (20%) | 23 (23%) | 0.771 |
| Percutaneous venous catheter | 40 (56%) | 36 (36%) | 0.011 |
| Duration of use (days) | 18.02 (16.00) | 17.61 (15.57) | NS |
| Umbilical artery catheter | 57 (80%) | 81 (80%) | 0.856 |
| Duration of use (days) | 7.58 (4.39) | 6.26 (2.51) | 0.013 |
| Central venous catheter | 13 (18%) | 21 (21%) | 0.835 |
| Duration of use (days) | 14.69 (11.25) | 21.28 (11.26) | <0.001 |
| Meconium stained amniotic fluid | 16 (23%) | 9 (9%) | 0.023 |
| Hyperbilirubinaemia | 60 (85%) | 80 (79%) | 0.496 |
| Phototherapy | 59 (83%) | 68 (68%) | 0.032 |
| Low Apgar score | 30 (42%) | 27 (27%) | 0.049 |
| Respiratory distress syndrome | 63 (89%) | 83 (82%) | 0.334 |
| Mechanical ventilation | |||
| Frequency | 58 (82%) | 73 (72%) | 0.213 |
| Length (days) | 13.38 (15.07) | 13.99 (16.07) | NS |
| Oxygen supplementation | 8 (11%) | 1 (1%) | 0.008 |
| Surfactant requirement | 52 (73%) | 61 (60%) | 0.113 |
| Patent ductus arteriosus | 31 (44%) | 28 (28%) | 0.049 |
| Sepsis | 16 (23%) | 18 (18%) | 0.569 |